HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of adenocarcinoma of lung cancer with multiple brain metastasis and lymphangitis carcinomatosa responding well to chemotherapy with carboplatin, etoposide and ifosfamide].

Abstract
A 75-year-old male who suffered from adenocarcinoma of lung cancer with multiple brain metastases, developed left hemiplegia. After diagnosis, he was treated with 4,000 cGy whole brain radiation, but soon after advanced lymphangitis carcinomatosa set in and his general condition deteriorated. He was administered carboplatin combination with etoposide and ifosfamide. Lymphangitis carcinomatosa disappeared, and the main tumor of lung and brain metastases were not growing. We recommended carboplatin for an old patient or one in poor condition, because it had less cytotoxicity and retained the same antitumor activity compared with cisplatin.
AuthorsK Hojo, Y Kumasaka, S Nishiyama, T Higashihara, Y Oku, M Okada, K Kajiyama
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 19 Issue 14 Pg. 2403-6 (Dec 1992) ISSN: 0385-0684 [Print] Japan
PMID1463347 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Etoposide
  • Carboplatin
  • Ifosfamide
Topics
  • Adenocarcinoma (complications, drug therapy, radiotherapy, secondary)
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Brain Neoplasms (complications, drug therapy, radiotherapy, secondary)
  • Carboplatin (administration & dosage)
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Cranial Irradiation
  • Etoposide (administration & dosage)
  • Humans
  • Ifosfamide (administration & dosage)
  • Lung Neoplasms (complications, pathology)
  • Lymphangitis (drug therapy, etiology)
  • Male
  • Radiotherapy Dosage

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: